PALFORZIA

Indicated For

Peanut allergy

About This Medication

# PALFORZIA Pathway Patient Assistance Program Patient Guide: How to Get PALFORZIA (Peanut (Arachis hypogaea) Allergen Powder-dnfp) at Low or No Cost PALFORZIA is an oral immunotherapy medication that helps reduce the severity of allergic reactions, including anaphylaxis, from accidental peanut exposure in patients with a confirmed peanut allergy. The **PALFORZIA Pathway Patient Assistance Program** from Stallergenes Greer provides this treatment at low or no cost to eligible underinsured or uninsured patients.[1][2][9] ## About PALFORZIA **PALFORZIA** [Peanut (Arachis hypogaea) Allergen Powder-dnfp] is a prescription powder derived from peanuts, designed specifically for people with peanut allergies. It works through gradual dose escalation to desensitize patients, raising their threshold for reacting to small, hidden amounts of peanut in food. This can mitigate severe reactions like anaphylaxis from accidental exposure, though it is **not a cure** and does not treat active allergic reactions.[1][2][7][8] Treatment starts with **Initial Dose Escalation** (typically in patients aged 4-17 years, observed by an allergist), followed by **Up-Dosing** and **Maintenance** phases. Doses must be taken daily with a meal, alongside a strict peanut-avoidant diet. Patients aged 1-17 can initiate (with some sources noting 4+), and treatment may continue into adulthood if tolerated. Always carry epinephrine and seek immediate medical help for reactions, as side effects like allergic responses are expected and more likely within 1 hour post-dose.[1][5][8][9] PALFORZIA is administered orally by mixing powder from capsules into food—never swallowed whole. It's only for peanut allergy, not other food allergies.[1][2] ## Who Qualifies for the Program? The program targets **underinsured or uninsured patients** facing financial hardship with access to PALFORZIA. A confirmed peanut allergy diagnosis from your doctor is required, along with proof of insurance status. While specific income thresholds are not publicly detailed (contact the program for personalized assessment), eligibility focuses on those unable to afford treatment due to lack of coverage or high costs.[9] **Key eligibility factors**: - Diagnosed peanut allergy (patients 4+ years for initiation, continuable in adults). - Underinsured (limited coverage) or uninsured. - U.S. residents (program is U.S.-based). - Willingness to commit to daily dosing and medical supervision. ## Income Eligibility Breakdown Specific income thresholds are not specified in program details, as eligibility is determined case-by-case based on financial documentation. Applicants submit proof like tax returns or pay stubs for review. Here's a general guide to what programs like this often consider (consult the program for exact criteria): | Household Size | Typical Low-Income Threshold (e.g., 400-500% FPL) | Notes | |---------------|---------------------------------------------------|-------| | 1 | Up to $60,000-$75,000 annually | Varies; no hard caps listed. | | 2 | Up to $80,000-$100,000 | Submit docs for verification. | | 3 | Up to $100,000-$125,000 | Focus on out-of-pocket costs. | | 4 | Up to $120,000-$150,000 | Add ~$20k-25k per additional member. | | 5+ | Scaled accordingly | Program reviews holistically. | This table is illustrative; call (844) 725-3679 for your situation. No income limits mean some insured patients with high copays may qualify.[9] ## Insurance Requirements The program serves **underinsured or uninsured patients**. Provide proof of insurance status (e.g., denial letter, EOB showing high costs, or uninsured declaration). Medicare patients may qualify if facing coverage gaps, but confirm via phone—many assistance programs cover Medicare Part D gaps. Commercial insurance with high deductibles/copays often eligible. Full coverage? Likely ineligible.[9] ## Step-by-Step Application Process 1. **Consult your allergist**: Get a confirmed peanut allergy diagnosis and prescription for PALFORZIA. Discuss if you're a candidate (e.g., age 4+, no uncontrolled asthma). 2. **Contact the program**: Call **(844) 725-3679** to speak with a representative. They'll guide you and send the enrollment form. 3. **Gather documents**: - Completed **enrollment form** (patient/doctor signatures). - **Proof of insurance status** (insurance card, denial letter, or uninsured affidavit). - **Financial documentation** (recent tax return, pay stubs, W-2s, bank statements). 4. **Submit via fax**: Fax everything to the provided number (given on call). No online portal listed. 5. **Follow up**: Track status by phone. **Reauthorization is required** periodically—your doctor resubmits proof of ongoing need. Applications are reviewed for financial need and medical appropriateness.[9] ## Timeline and Delivery Processing time varies (typically 1-4 weeks, based on similar programs—call for updates). Once approved, medication is **shipped directly to your home** free of charge. Expect initial supply for dose escalation, then maintenance packs. Refills require reauthorization; plan ahead to avoid gaps. Daily adherence is crucial for efficacy.[1][9] ## Alternatives if Denied - **Appeal**: Submit additional financial/insurance docs or doctor letter explaining need. - **Other assistance**: Check PAN Foundation, NeedyMeds, or RxAssist.org for peanut allergy/epinephrine alternatives. - **Manufacturer exceptions**: Request hardship review. - **Generic/low-cost options**: No biosimilars for PALFORZIA; consider clinical trials or off-label therapies via allergist. - **State programs**: Medicaid expansions or charity care clinics. No biosimilar alternatives listed.[9] ## Important Disclaimer This guide is for informational purposes only and not medical/financial advice. Eligibility, terms, and availability can change—verify with Stallergenes Greer at (844) 725-3679 or your healthcare provider. PALFORZIA carries risks like anaphylaxis; read the full Medication Guide and Prescribing Information. Always follow your doctor's instructions and maintain a peanut-free diet. Program details current as of latest info; contact for updates. (Word count: 1028)

Program information last verified: March 30, 2026